|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/16/23 G Medical Innovations Holdin… Ltd 6-K 5/16/23 2:40K EdgarAgents LLC/FA |
Document/Exhibit Description Pages Size
1: 6-K Report of Foreign Private Issuer HTML 12K
2: EX-99.1 Press Release Titled: "G Medical Innovations HTML 13K
Holdings Ltd. Announces Receipt of Nasdaq Hearings
Panel's Decision to Grant Exception for Continued
Listing."
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of May 2023
Commission file number: 001-39674
G MEDICAL INNOVATIONS HOLDINGS LTD.
(Translation of registrant’s name into English)
5 Oppenheimer St.
Rehovot 7670105, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
CONTENTS
On May 15, 2023, G Medical Innovations Holdings Ltd. (the “Company”) issued a press release titled “G Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Hearings Panel’s Decision to Grant Exception for Continued Listing.” A copy of this press release is furnished herewith as Exhibit 99.1.
The press release included as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s Registration Statement on Form F-3 (File No. 333-266090) and on Form S-8 (File No. 333-266063), filed with the SEC, to be a part thereof from the date on which this Report is submitted to the extent not superseded by documents or reports subsequently filed or furnished.
1
EXHIBITS
| Exhibit No. | Description | |
| 99.1 | Press release titled: “G Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Hearings Panel’s Decision to Grant Exception for Continued Listing.” |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| G Medical Innovations Holdings Ltd. | |||
| Date: May 16, 2023 | By: | /s/ Yacov Geva | |
| Name: | Yacov Geva | ||
| Title: | Chief Executive Officer | ||
3
| This ‘6-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on / For Period end: | 5/16/23 | 20-F | ||
| 5/15/23 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/27/23 G Medical Innovations Holdin… Ltd F-1 14:1M EdgarAgents LLC/FA 7/05/23 G Medical Innovations Holdin… Ltd S-8 7/05/23 5:234K EdgarAgents LLC/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/11/22 G Medical Innovations Holdin… Ltd F-3 5:365K EdgarAgents LLC/FA 7/08/22 G Medical Innovations Holdin… Ltd S-8 7/08/22 4:189K EdgarAgents LLC/FA |